Businesses rush in to capitalise on medical marijuana mania


The recent legalisation of medical marijuana in Thailand is spurring active efforts to investigate and develop the plant’s medicinal properties. Earlier this year, the government legalised medical marijuana citing research suggesting that cannabis may be beneficial in treating some chronic conditions.

Despite the fairly ambiguous and unspecific wording in the legislation, many companies are now actively pursuing a profitable future from exploiting the current interest surrounding the plant and the legislation that decriminalised its use in Thailand.

Several organisations have unveiled their plans. For instance, the Government Pharmaceutical Organisation (GPO) has said it hopes to start producing cannabinoid medicines on an industrial level, while several universities have rushed to forge collaboration with the Khao Kwan Foundation, which has long experimented with

Ga naar Bron